On May 14, 2025, Keybanc analyst Matthew Gillmor reaffirmed the "Overweight" rating for Acadia Healthcare Co (ACHC, Financial). Despite maintaining the rating, Keybanc adjusted the price target for ACHC, lowering it from $65.00 to $55.00.
The adjustment reflects a 15.38% decrease in the price target, as reported by Keybanc. The decision comes amidst ongoing evaluations, with the currency exchange based in USD.
The current price target of $55.00 suggests potential adjustments in market expectations for ACHC. Investors should stay informed on further updates and analyses regarding Acadia Healthcare Co's performance on the NASDAQ exchange.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 14 analysts, the average target price for Acadia Healthcare Co Inc (ACHC, Financial) is $43.00 with a high estimate of $72.00 and a low estimate of $28.00. The average target implies an upside of 59.61% from the current price of $26.94. More detailed estimate data can be found on the Acadia Healthcare Co Inc (ACHC) Forecast page.
Based on the consensus recommendation from 14 brokerage firms, Acadia Healthcare Co Inc's (ACHC, Financial) average brokerage recommendation is currently 1.9, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Acadia Healthcare Co Inc (ACHC, Financial) in one year is $93.44, suggesting a upside of 246.84% from the current price of $26.94. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Acadia Healthcare Co Inc (ACHC) Summary page.
